Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Endorex receives Japanese patent for ImmTher

Sep. 23, 1998

Cell Genesys announces positive phase I/II results using GVAX vaccine for prostate cancer

Sep. 22, 1998

IL-4(38-37)-PE38KDEL treatment results in complete regression of human glioblastoma tumors

Sep. 21, 1998

York Medical's DiaCIM will be administered to cancer patients

Sep. 18, 1998

Techniclone submits phase II TNT protocol to FDA

Sep. 18, 1998

Maxim enters collaborative agreement with BioNative

Sep. 15, 1998

Imutec reports positive phase I/II results for Virulizin

Sep. 7, 1998

New biologic for breast cancer receives advisory committee approval

Sep. 3, 1998

Phase I/II trial provides evidence of potential efficacy of ovarian cancer vaccine

Sep. 2, 1998

Medarex receives milestone payment from Merck KGaA

Sep. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...